RecruitingNCT06724224

Comparison of Levothyroxine Formulations in the Treatment of Congenital Hypothyroidism


Sponsor

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Enrollment

120 participants

Start Date

Apr 8, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

Observational, retrospective, prospective, pharmacological, single-centre, non-profit study. The aim is to evaluate, in newborns diagnosed with Congenital Hypothyroidism, the medium- and long-term efficacy and safety of the new formulation of levothyroxine in oral solution, compared to the liquid drop formulation and the tablet formulation. The study will involve male and female patients referred to the Neonatal Screening Centre at the Centre for Endocrine-Metabolic Diseases of the Paediatrics Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna Policlinico di S. Orsola, Italy, who tested positive for Congenital Hypothyroidism.


Eligibility

Max Age: 11 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with congenital hypothyroidism. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Bologna, Bologna, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06724224


Related Trials